TRAIL ligation of cognate death-inducing receptors (TRAIL-R1 and TRAIL-R2 in humans, DR5 in mice) [11] triggers apoptotic death in tumor cells, thereby increasing the amount of tumor cell antigen potentially available for uptake and processing by local antigen-presenting cells (APCs) [10]. This evidence concerns the gene TNFRSF10B and neoplasm.